drugset / Trial / NCT03876119

Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy

NCT03876119

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Multicenter, randomized, placebo-controlled, double blind, phase 2b trial of acute stroke patients treated with mechanical thrombectomy (MT), in which two therapies are compared: rt-PA or placebo. Allocation at each center will account for 1 stratum: use of alteplase (yes vs. no) before MT. Subjects will be followed up to 90 days post-randomization.

Timeline

Start
2018-12-05
Primary completion
2021-05-31
Completion
2021-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 0.225 mg/kg Other

Indications